Related Experiment Video
Updated: Feb 10, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant
Caitlin S Latimer1, Jennifer Schleit2, Adam Reynolds3
1Department of Pathology, Neuropathology Division, University of Washington Medical Center, Seattle, WA.
Abstract:
Neutral lipid storage disease with myopathy is a rare disorder of lipid metabolism caused by variants in the Patatin-Like Phospholipase Domain Containing 2 (PNPLA2) gene. Diagnosis is often delayed due to variable presentations, which is of concern due to increased risk of cardiomyopathy. Better phenotype-genotype characterization is necessary to improve speed and accuracy of diagnosis. Here, we describe a 32-year-old woman of Hmong descent with progressive muscle pain and weakness who had a muscle biopsy with characteristic features of a lipid storage myopathy. Genetic testing revealed a homozygous splice site variant in PNPLA2, c.757 + 1G > T. This case, in combination with the one previously reported case of this PNPLA2 variant, also in a family of Hmong descent, suggests this particular variant may be unique to the Hmong population, a Southeast Asian minority group living in the United States, who immigrated to the United States as refugees after the Vietnam War.
Related Concept Videos
Histone Variants at the Centromere
Structure of Lipids
Storage
What are Lipids?
Acids, Bases and Neutralization Reactions
Lipid Digestion

